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Abstract
Background: Debates over the importance of “lifestyle” versus “environment” contributions to cancer have been
going on for over 40 years. While it is clear that cigarette smoking is the most significant cancer risk factor, the
contributions of occupational and environmental carcinogens in air, water and food remain controversial. In
practice, most cancer prevention messaging focuses on reducing cigarette smoking and changing other personal
behaviors with little mention of environmental chemicals, despite widespread exposure to many known
carcinogens. To inform decision-making on cancer prevention priorities, we evaluated the potential impact of
smoking cessation on cancer rates.
Methods: Using cancer incidence data from 612 counties in the SEER database, and county-level smoking
prevalences, we investigated the impact of smoking cessation on incidence for 12 smoking-related cancer types,
2006—2016. A multilevel mixed-effects regression model quantified the association between county-level smoking
prevalence and cancer incidence, adjusting for age, gender and variability over time and among counties. We
simulated complete smoking cessation and estimated the effects on county-level cancer rates.
Results: Regression models showed the expected strong association between smoking prevalence and cancer
incidence. Simulating complete smoking cessation, the incidence of the 12 smoking-related cancer types fell by
39.8% (54.9% for airways cancers; 28.9% for non-airways cancers). And, while the actual rates of smoking-related
cancers from 2006 to 2016 declined (annual percent change (APC) = − 0.8, 95% CI = − 1.0 to − 0.5%), under the
scenario of smoking elimination, the trend in cancer incidence at these sites was not declining (APC = − 0.1, 95%
CI = − 0.4 to + 0.1%). Not all counties were predicted to benefit equally from smoking elimination, and cancer rates
would fall less than 10% in some counties.
Conclusions: Smoking prevention has produced dramatic reductions in cancer in the US for 12 major types.
However, we estimate that eliminating smoking completely would not affect about 60% of cancer cases of the 12
smoking-related types, leaving no improvement in the incidence trend from 2006 to 2016. We conclude that
cancer prevention strategies should focus not only on lifestyle changes but also the likely contributions of the full
range of risk factors, including environmental/occupational carcinogens.
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Introduction
Cancer prevention efforts focus primarily on changing
personal behaviors – including smoking, diet, exercise,
sun safety, and adherence to screening. Of these, it is wellaccepted that smoking is the most important, accounting
for as much as 19% of all cancer incidence while other
“lifestyle” factors have more modest contributions [1].
There is also a substantial body of evidence linking
environmental chemicals to cancer, although how and
whether this information should be used in cancer
prevention initiatives is more controversial [2–4]. The
U.S. President’s Cancer Panel (PCP), concluding their
2010 report on Reducing Environmental Cancer Risk
stated: “The burgeoning number and complexity of
known or suspected environmental carcinogens compel us
to act to protect public health, even though we may lack
irrefutable proof of harm” [2]. Some leading experts disagreed [3]. For example, writing in the New England
Journal of Medicine, Willett, Colditz and Hiatt [5]
argued that the PCP was misguided in its emphasis on
environmental carcinogens: “It is important not to
detract from the fact that the major causes of cancer are
smoking, overweight, and inactivity.” But if talking about
environmental carcinogens “detracts” from attention to
smoking, overweight and inactivity, the public, policymakers and clinicians might be forgiven for concluding
that all people need to do to prevent cancer is to change
their unhealthy behaviors.
Debates over “lifestyle” versus “environment” contributions to cancer are longstanding (going back at least as
far as Doll and Peto’s 1980 report [6]) and unlikely to be
resolved anytime soon because of inadequate human
carcinogenicity data. We therefore proposed a different
approach to provide perspective on this debate. With
data relevant for county-level decision-making, we simulated the best possible case of a behavioral intervention
to prevent cancer – the complete elimination of smoking
– and then estimated the resulting reduction in the rate
of cancer, focusing only on cancer sites for which smoking is a known risk factor. How much would cancer
rates fall, and how much cancer would remain? Would
this best-case scenario prevent the large majority of cancers? If not, perhaps additional modifiable risk factors
should be sought and addressed.
Using a multi-level statistical model of county-level
U.S. cancer incidence data, we investigated three questions: 1. What proportion of the cancer incidence at 12
smoking-related cancer sites would remain if smoking
were completely eliminated? 2. How would the 11-year
trend (2006–2016) in 12 smoking-related types of cancer
have been different if smoking had been completely
eliminated? 3. How would the county-by-county variability in cancer rates at the 12 smoking-related sites change
if smoking were completely eliminated?
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Materials and methods
Cancer incidence data by county were obtained from 18
cancer registries participating in the Surveillance,
Epidemiology, and End Results (SEER) program of the
National Cancer Institute (NCI), representing the highest quality cancer U.S. registry data available and covering about 28% of the US population [7]. SEER data
contain cancer incidence information, as well as patient
demographics and clinical characteristics including stage
and grade. Reliable individual smoking data are not
available from SEER, so county-level prevalence data
were used instead (see below). All counties in SEER were
included in the analysis, except Alaska where the registry
only includes Native Alaskans. Population data are also
provided. Because all data were publicly available and
not personally identifiable, Institutional Review Board
approval was not required.
We chose to study 12 cancer types which are considered to be caused by smoking according to the U.S.
Centers for Disease Control and Prevention [8]. These
can be divided into two groups – three airways cancers
and nine other smoking-related cancers.
Airways cancers

1. Trachea, bronchus and lung (ICD-O-3 codes C33.9–
34.9).
2. Larynx (C32.0–32.9).
3. Oral cavity and pharyngeal (C00–14.8).
Other smoking-related cancers

4. Esophagus (C15.0–15.9).
5. Stomach (C16.0–16.9).
6. Colon and rectum (C18.0–20.9).
7. Liver (C22.0).
8. Pancreas (C25.0–25.9).
9. Kidney and renal pelvis (C64.9–65.9).
10. Urinary bladder (C67.0–67.9).
11. Cervix (C53.0–53.9).
12. Acute myeloid leukemia (ICD-O-3 histology codes
9840, 9861, 9865–9867, 9869, 9871–9874, 9895–9898,
9910–9911, and 9920).
As the SEER incidence data provide county of residence information, the county (n = 612) was the unit of
analysis. Independent variables were available at either
the individual level or county level. Individual level
variables for each case were: year of diagnosis (2006–
2016); gender; and age, in 5-year categories (20–24, …,
80–84). Cancer data for all races were included, but race
effects were not modeled because of the very small numbers of non-whites in many of the SEER counties. At the
county level we used the age-standardized calendar yearand gender-specific smoking prevalence, obtained from
the Institute for Health Metrics and Evaluation [9].
These estimates were based on Behavioral Risk Factor
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Surveillance System (BRFSS) data, which were modeled
to generate estimates of county level smoking prevalence
for the entire US for the period between 1996 and 2012.
The variable was defined as “prevalence of current daily
cigarette smoking”.
Statistical analyses were performed using multilevel
mixed-effects regression models in STATA/MP 16.0
[10]. We modeled cancer incidence rates by using observed cancer counts as the dependent variable and
person-time at risk as the offset. The observed counts
were modeled assuming a negative binomial distribution,
based on the presence of over-dispersion; incidence rate
ratios and 95% confidence intervals were generated. The
fixed-effect part of the model included the following covariates (selected a priori and forced into the models):
age, gender, calendar year, age-adjusted daily smoking
prevalence by county and year. In models of the full 11year period, a 10-year lag was used for the smoking data,
which was the longest lag possible because the smoking
data were available only from 1996 onwards. We also fit
a model for the latest year, 2016, and in this case, we fit
smoking data lagged 20 years. A random intercept was
assumed by county and a random slope by year (different effects of calendar year by county). We also fit
models stratified by gender rather than including gender
as a covariate. After fitting the model, we used the “predict” command in STATA to generate predicted counts
of cancers by county and year which were then converted to expected rates using county populations, which
were then age-standardized to the gender-specific SEER
population distribution for 2016. Smoking is a much
stronger risk factor for airways cancers than the other
nine sites, so to more accurately estimate the effects of
smoking and its elimination, we fit models separately for
these two subgroups.
Trends by year were computed from both the fixedand random-effects parts of the model; likewise, the
county-by-by county variation was also computed including the fixed- and random-effects parts of the
model. We used the model to compare two scenarios:
the actual incidence rates, assuming the observed lagged
county smoking prevalences (lagged 10 years for the 11year trend models; lagged 20 years for the 2016 only
models), and the smoking eliminated scenario. To obtain
these simulated results, the value of smoking prevalence
in each county was set to zero. Predicted values were obtained under this scenario, again via STATA’s “predict”
command, then age-standardized to the gender-specific
SEER population distribution for 2016 as were values
obtained using the actual smoking prevalence data. To
evaluate the annual trends, we fitted a log-linear model
to the rates predicted from the above regression models.
The annual percent change (APC) was estimated as the
100 * exponential of (beta – 1) [11].
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After fitting the model estimating the effects of smoking elimination (county smoking prevalence set to zero),
we predicted the rates of the smoking-related cancers in
each county in 2016. Using 2016 county populations as
weights, we then evaluated the county-by-county distribution of cancer rates across the total SEER population
(n = 64,999,165).

Results
The mean smoking prevalence for the 612 counties in
2016 (lagged 10 years) was 20.0% (SD = 5.0%, 5th percentile = 11.6%, 95th percentile = 28.2%). Cancer incidence
rates were calculated by gender for each of the types of
cancer associated with smoking, from the SEER data for
the years 2006–2016 (Supplemental Table 1). These
cancer sites included 35% of all cancers among women
and 47% among men. For the 12 smoking-related sites
combined, the annual age-standardized incidence rates
declined over the 11 years in both men and women (Fig. 1,
solid lines).
Next, three multivariate regression models, each
accounting for the effects of age and gender and year of
diagnosis, are shown in Table 1. The very strong increasing trend in incidence of cancer with age is easily seen
in this table, as is the overall higher incidence among
men compared to women – a more than 60% higher risk
for the 12 smoking-related sites overall among men.
One can also see the modest but clear decline in the
incidence of these cancers over the time period 2006–
2016; with 2006 set as the reference year, the relative
risk of cancer declines over the years so that by 2016 the
relative risk was 0.90, or a 10% decrease, compared to
2006. Fitting linear trends to the annual data for men
and women, the annual percent changes were − 1.0%
(95% CI = − 1.3% to − 0.8%) and − 0.6% (95% CI = − 0.8%
to − 0.3%), respectively (combined: -0.8, 95% CI = − 1.0
to − 0.5%, Fig. 1).
Table 2 shows three additional regression models, each
accounting for the effects of age, gender, year of diagnosis as well as each county’s prevalence of current
smokers. This table includes models stratified by airways
and non-airways cancers (Table 2). For an initial
descriptive model, the smoking prevalence data were
categorized into six groups, with the lowest prevalence
group (4.5 to 10% current smokers) as the reference.
The strong association between smoking and these 12
types of cancer is clearly seen. In particular, the risk of
airways cancers (second column of rate ratios in Table
2) increased strongly as the smoking prevalence increased. In the highest smoking counties (those with
22.9 to 38.3% current smokers), the risk of these cancers
was more than double (RR = 2.19) that of the lowest
smoking prevalence counties. Risk of the other smokingrelated cancer sites also clearly increased as the smoking
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Fig. 1 Gender-stratified trends of smoking-related cancers under two scenarios: as observed and the simulated elimination of smoking

prevalence increased, but not as strongly, rising to RR =
1.32 – a 32% increase in risk in the highest smoking
counties.
The model summarized in Table 2 quantifies the effects on cancer incidence explained by age, gender, year
and smoking. By fixing the values of any of these inputs
to the model, it is possible to simulate different scenarios. To estimate the incidence rates of these 12 cancers
over this time period in the SEER counties had smoking
been completely eliminated, we again fit the model in
Table 2, except that smoking prevalence was coded with
a single continuous variable rather than six categories,
and set to zero for all observations when obtaining
predicted values.
As expected, under the scenario of complete smoking
elimination, the incidence rates were substantially lower
(Fig. 1, dashed lines) compared to the actual cancer incidence (Fig. 1, solid lines). For the final year, 2016, declines were 40.0 and 36.9% for males and females,
respectively. Also, under the assumption that smoking
had been completely eliminated, the modest downward
trends in rates were no longer evident. The model predicted essentially no change in the cancer incidence over
the 11-year period in either men or women.
As noted, the impact of smoking is considerably stronger for the airways cancers than for the other smokingrelated sites. Analyzing the effect of smoking elimination
on these two groups separately in 2016 (with a 20-year
lag for the smoking data), we found that incidence of the
airways cancers would decline by 54.9%, while for the
non-airways sites, the decline would be 28.9% (Fig. 2).
Overall, there would be a reduction of 39.8% in the incidence of smoking-related cancers in 2016 if smoking

were completely eliminated (using a 10-year lag would
result in a 51.4% drop in cancers of the airways, a 23.4%
drop of non-airway cancers and a combined decrease of
35.2%).
We examined county-by-county variability under the
smoking elimination scenario in 2016. Not all counties
would see the same degree of cancer reduction from
smoking elimination (Fig. 3). Not surprisingly, the counties that would see the largest benefits from smoking
elimination have high smoking prevalences. For example,
the 20 counties with the highest rates of smokingrelated cancers in 2016 had an average smoking prevalence nearly twice the overall average (32% versus 18%)
and all 20 counties were in Kentucky. But there would
also be counties which would benefit less from smoking
elimination. For example, there are five counties with
predicted cancer rates after eliminating smoking that are
greater than 280/100,000 (Fig. 3, right tail of the smoking eliminated distribution). These are all in the metropolitan areas of large cities: Jefferson County KY
(Louisville) (smoking prevalence = 20.6%), Wayne and
Macomb counties MI (Detroit) (smoking prevalence =
20.7 and 20.9%, respectively), Campbell County KY (Cincinnati) (smoking prevalence = 23.4%), and Jefferson Parish LA (New Orleans) (smoking prevalence = 23.8%). If
smoking were eliminated, we predict that these counties
would have smoking-related cancer rates that are about
the same as the current average rate for all 612 SEER
counties (left bar in Fig. 2). The model predicts that
these five counties would see only an approximate 8%
reduction in their rates of smoking-related cancers, far
less than the overall average of about 40%, after total
smoking elimination.
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Table 1 Incidence rate ratios for determinants (excluding smoking) of all cancers, smoking-relateda and non-smoking-related
cancersb
All Cancers

All Smoking-related Cancers

All Non-smoking-related Cancers

IRR

(95% CI)

IRR

(95% CI)

IRR

(95% CI)

20–24

1

(Ref.)

1

(Ref.)

1

(Ref.)

25–29

1.64

(1.61–1.68)

2.09

(2.00–2.18)

1.56

(1.53–1.60)

30–34

2.56

(2.51–2.61)

4.03

(3.88–4.19)

2.30

(2.25–2.35)

35–39

3.86

(3.79–3.93)

6.80

(6.56–7.05)

3.31

(3.25–3.38)

40–44

6.12

(6.02–6.23)

11.98

(11.57–12.42)

5.01

(4.91–5.11)

45–49

9.85

(9.68–10.01)

21.76

(21.01–22.53)

7.55

(7.41–7.70)

50–54

15.81

(15.54–16.07)

39.80

(38.45–41.19)

11.34

(11.13–11.56)

55–59

23.44

(23.06–23.83)

59.41

(57.41–61.48)

16.84

(16.53–17.15)

60–64

33.25

(32.71–33.80)

87.89

(84.94–90.95)

23.60

(23.17–24.04)

65–69

46.43

(45.68–47.20)

130.40

(126.02–134.93)

31.83

(31.26–32.42)

70–74

55.36

(54.46–56.28)

171.15

(165.40–177.10)

35.93

(35.27–36.60)

Variable
Age at diagnosis

75–79

62.19

(61.18–63.23)

208.92

(201.90–216.19)

38.17

(37.47–38.89)

80–84

65.10

(64.03–66.19)

232.89

(225.04–241.01)

38.07

(37.36–38.80)

Women

1

(Ref.)

1

(Ref.)

1

(Ref.)

Men

1.16

(1.16–1.17)

1.61

(1.60–1.61)

0.96

(0.96–0.97)

2006

1

(Ref.)

1

(Ref.)

1

(Ref.)

2007

1.01

(1.00–1.03)

0.99

(0.97–1.02)

1.03

(1.01–1.04)

2008

1.01

(0.99–1.02)

0.99

(0.96–1.02)

1.01

(1.00–1.03)

2009

1.00

(0.98–1.02)

0.98

(0.95–1.00)

1.01

(0.99–1.03)

2010

0.98

(0.97–1.00)

0.95

(0.93–0.98)

1.00

(0.98–1.02)

2011

0.98

(0.97–1.00)

0.94

(0.92–0.97)

1.00

(0.99–1.01)

2012

0.97

(0.96–0.99)

0.95

(0.93–0.98)

0.98

(0.96–0.99)

2013

0.96

(0.94–0.97)

0.93

(0.91–0.96)

0.97

(0.95–0.98)

2014

0.97

(0.96–0.99)

0.95

(0.92–0.97)

0.97

(0.96–0.99)

2015

0.97

(0.96–0.99)

0.93

(0.91–0.96)

0.98

(0.97–1.00)

2016

0.95

(0.94–0.97)

0.90

(0.88–0.93)

0.97

(0.96–0.99)

Gender

Year of diagnosis

Abbreviations: CI Confidence interval; IRR Incidence rate ratio; Ref Reference
a
Smoking-related cancer sites classified according to [8].
b
Estimates from three negative binomial regression models with random intercept on county and random slope on year. SEER 18 registries, 2006–2016, Alaska
Native Tumor Registry excluded because of the lack of information on county

Discussion
Overall cancer incidence in the U.S. has been falling over
the past several decades [12]. This has been attributed
largely to the reduction in smoking prevalence, especially
among men. We were interested in investigating the role
of changes in smoking habits on the incidence of cancer,
and in particular we wanted to answer the hypothetical
question: “Suppose smoking cessation were completely
effective and smoking was entirely eliminated as a cause
of cancer. How much cancer would still remain?” We focused therefore on cancer incidence at 12 sites known to

be linked to smoking; cancer risk at other sites would
not be affected by changes in smoking, and so we
excluded them from our analyses.
We draw three main conclusions: First, by simulating
the impact of the elimination of smoking on cancer
rates, we estimated that about 60% of the cancers at
tumor sites considered to be smoking-related would still
occur (60% for males, 63% for females) in the absence of
smoking. Second, under the same simulated condition of
no smoking, the 11-year trend in the incidence rate of
these 12 types of cancer would have been stable –
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Table 2 Airways and non-airways stratified incidence rate ratios for determinants (including smoking) of smoking-relateda cancersb
Variable

All smoking-related cancers

Smoking-related cancers of the airways

Other smoking-related cancers (non–airways)

IRR

IRR

IRR

(95% CI)

(95% CI)

(95% CI)

Age at the diagnosis
20–24

1

(Ref.)

1

(Ref.)

1

(Ref.)

25–29

2.09

(2.00–2.18)

1.69

(1.55–1.85)

2.21

(2.11–2.32)

30–34

4.03

(3.88–4.18)

2.99

(2.75–3.24)

4.35

(4.17–4.55)

35–39

6.80

(6.55–7.05)

5.65

(5.238–6.09)

7.19

(6.89–7.50)

40–44

11.98

(11.56–12.42)

12.60

(11.71–13.55)

11.86

(11.39–12.35)

45–49

21.76

(21.01–22.53)

30.23

(28.16–32.46)

19.18

(18.43–19.97)

50–54

39.79

(38.44–41.18)

62.32

(58.08–66.87)

32.88

(31.60–34.21)

55–59

59.36

(57.36–61.44)

105.06

(97.93–112.72)

45.37

(43.61–47.19)

60–64

87.73

(84.77–90.97)

162.40

(151.39–174.21)

65.05

(62.54–67.66)

65–69

130.08

(125.70–134.61)

248.44

(231.60–266.49)

94.28

(90.65–98.06)

70–74

170.58

(164.84–176.52)

331.66

(309.19–335.77)

122.6

(117.88–127.52)

75–79

208.16

(201.14–215.41)

392.41

(365.81–420.95)

154.49

(148.53–160.69)

80–84

232.11

(224.28–240.23)

405.43

(377.91–434.95)

182.83

(175.76–190.18)

Women

1

(Ref.)

1

(Ref.)

1

(Ref.)

Men

1.46

(1.45–1.46)

1.35

(1.35–1.37)

1.53

(1.52–1.54)

2006

1

(Ref.)

1

(Ref.)

1

(Ref.)

2007

1.00

(0.98–1.02)

1.00

(0.97–1.03)

1.00

(0.99–1.02)

2008

1.00

(0.98–1.02)

1.00

(0.98–1.03)

1.01

(0.99–1.02)

2009

1.00

(0.98–1.01)

1.00

(0.98–1.03)

0.99

(0.97–1.01)

2010

0.99

(0.97–1.00)

0.99

(0.96–1.02)

0.98

(0.96–1.00)

2011

0.97

(0.95–0.99)

0.98

(0.95–1.00)

0.97

(0.95–0.98)

2012

0.99

(0.97–1.01)

0.99

(0.96–1.01)

0.99

(0.97–1.00)

2013

0.97

(0.95–0.99)

0.97

(0.94–0.99)

0.96

(0.95–0.98)

2014

0.99

(0.97–1.01)

0.99

(0.96–1.01)

0.99

(0.98–1.01)

2015

0.99

(0.97–1.01)

0.98

(0.96–1.01)

0.99

(0.97–1.01)

2016

0.97

(0.95–0.99)

0.97

(0.95–1.00)

0.97

(0.95–0.99)

(Ref.)

1

(Ref.)

1

(Ref.)

Gender

Year of diagnosis

Prevalence of daily smoking by county
4.5–10.0%

1

10.1–12.1%

1.05

(1.03–1.07)

1.09

(1.06–1.12)

1.05

(1.02–1.07)

12.2–15.6%

1.09

(1.07–1.11)

1.20

(1.17–1.23)

1.06

(1.04–1.08)

15.7–19.1%

1.17

(1.15–1.19)

1.36

(1.33–1.40)

1.11

(1.09–1.13)

19.2–22.8%

1.31

(1.28–1.34)

1.62

(1.58–1.67)

1.20

(1.17–1.22)

22.9–38.3%

1.58

(1.54–1.61)

2.19

(2.13–2.26)

1.32

(1.29–1.35)

Abbreviations: CI Confidence interval; IR Incidence rate
a
Smoking-related cancer sites classified according to [8]
b
Estimates from three negative binomial regression models with random intercept on county and random slope on year. SEER 18 registries, 2006–2016, Alaska
Native Tumor Registry excluded because of the lack of information on county

neither rising nor falling – suggesting that smoking cessation is almost entirely responsible for the reductions in
incidence that have occurred over this time period.
Third, the degree to which smoking elimination would

reduce cancer incidence rates would not be uniformly
distributed across the country. We predict that some
counties would have only modest reductions in cancer
from eliminating smoking and by extension higher rates
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Fig. 2 Smoking-related airways and non-airways cancer rates, 2016, under two scenarios: as observed and the simulated elimination of smoking

of cancers remaining. Future research might prioritize
identifying additional factors explaining these elevated
rates. Decision-makers should consider the potential
contribution of other cancer risk factors in addition to
smoking in designing comprehensive cancer prevention
programs.
We compared our results to other estimates of tobacco’s contribution to cancer incidence. Islami and

colleagues at the American Cancer Society recently published an extensive review of the potential for cancer
prevention from addressing modifiable risk factors, including smoking [1]. Using an entirely different method,
based on a synthesis of published estimates of the relative risks for different exposures, they concluded that in
2014, smoking was responsible for 19% of all incident
cancers in the U.S. Parkin and colleagues [13] arrived at

Fig. 3 Population distribution of county-level smoking-related cancer rates, 2016, under two scenarios: as observed and the simulated elimination
of smoking
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the same figure for the U.K. in 2010. Our estimate of
2016 data for the 40.9% of cancers that occur at the
12 smoking-related sites agrees very well with this: a
reduction of 39.8% for 40.9% of all cancers translates
to smoking being responsible for 16.3% of all cancers,
not very different from their estimate of 19%. This
gives us some confidence that our method, based on
patterns in county-level data from the SEER registries,
provided reasonable estimates for making national
inferences.
Islami and colleagues also estimated the proportions
of cancers in 2014 attributable to other lifestyle factors [1]. After smoking, the most important were excess body weight (7.8%), alcohol (5.6%) and physical
inactivity (2.9%). These relatively minor contributions
support our choice to focus this paper on smoking as
the single most important behavioral risk factor for
cancer.
The role of tobacco control in the decline in cancer
rates has been widely recognized [14]. Thun and
colleagues wrote: “The most striking success in [cancer] primary prevention is undoubtedly tobacco, where
falling consumption has resulted in marked reductions
in the incidence and death rates from … tobaccorelated cancers among men …” [15]. Our analyses did
not include cancers at the other sites, un-related to
smoking, but Han and colleagues did [16]. Over a
longer time period, 1975–2004, they found that for
cancers unrelated to tobacco (or cancer screening
which complicates the picture for several sites such as
prostate and breast), cancer incidence increased in
both men (0.88% annually for whites, 0.12% annually
for blacks) and women (0.69% annually for whites,
0.52% annually for blacks).
Without detracting from the importance of tobacco
control, these findings suggest that progress in the primary prevention of cancer must include many strategies,
not only those focused on healthy lifestyles but also reduction of carcinogen exposures wherever possible [17,
18]. Such exposures include urban air pollution, particularly diesel exhaust, water pollution, pesticides in food,
ionizing radiation and work-related chemicals [2]. Using
the same SEER county cancer incidence data (2006–
2010), Jagai and colleagues found a strong association
between all-site cancer incidence and a measure of overall environmental quality, the Environmental Quality
Index (which, developed by the U.S. EPA, combines
measures of environmental quality in five domains: air,
water, land, built environment and sociodemographic
factors) [19].
As noted in the introduction, there are disagreements
in the cancer prevention community about the importance of addressing environmental exposures [3]. Some
argue that because the proportion of cancers caused by
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environmental exposures (often called the attributable
fraction) is small relative to smoking and other health
behaviors, control of the former does not warrant attention as a prevention strategy. There are several
problems with this argument. First, cancers are
known to have multiple causes and the very concept
of apportioning different fractions of a disease rate to
different single causes is misleading [20]. For a multifactorial disease, attributable fractions must add to
more than 100% — probably much more, but calculations of attributable fractions for cancer causes often
do not [1, 21].
A second major problem with the calculation of attributable fractions is that they measure the impact of
the complete removal of the exposure. The complete
elimination of smoking is probably impossible, at least
in a democratic society. The most recent U.S. Preventive Services Task Force evaluation of the effectiveness
of smoking cessation strategies found the best strategies have success rates of 28% or less [22]. Therefore,
if we want to decide how much to prioritize tobacco
control strategies, we should understand that 19% –
Islami’s estimate of the percent of all cancers caused
by smoking – is probably not a realistic goal for prevention. In our analyses, we chose to use the unrealistic assumption of smoking elimination because our
intent was to place a lower bound on the proportion
of the smoking-related cancers that would not be prevented by tobacco control. Also, we wanted to be able
to compare our results to others, like Islami, who used
a more conventional approach to estimating attributable fractions.
An important limitation of this study was the lack of
individual level smoking data. Using lagged countylevel smoking prevalence was an imprecise proxy for
personal smoking data with individual information on
amount smoked, duration, etc. Data availability prevented us from applying a 20-year lag to the model for
the full 11-year period (Fig. 1), but the results for 2016
using the 10- versus 20-year lagged smoking data were
very similar (35.2% versus 39.8%, respectively). We
therefore doubt that the time trend in Fig. 1 would have
been importantly changed if the longer lag could have
been used. Despite the limitations in the smoking data,
we were reassured that our estimate of the size of the
reduction in cancer incidence assuming smoking elimination was in good agreement with others who have
used entirely different methods to arrive at a similar result [1]. Another limitation is that smoking, whether
measured individually or geographically, is often correlated with other cancer risk factors including air pollution, occupational exposures and dietary factors. We
were unable to remove the potentially confounding or
modifying effects of these factors on estimates of the
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effect of smoking elimination. This would likely lead to
an overestimation of the reduction in cancers observed
by simulating the elimination of smoking. A strength of
the ecological assessment of smoking patterns is that it
should capture variability in secondhand smoking as
well as active smoking. Therefore, these estimates of
the benefits of smoking cessation would also include
cancer prevention from eliminating secondhand
exposure.

Consent for publication
Not applicable.

Conclusions
While smoking cessation unquestionably continues to be
a very important cancer prevention strategy, it cannot be
anticipated to prevent the majority of cancers, even
those for which smoking is a known risk factor. Particularly in counties where incidence rates of cancer would
remain high even if smoking cessation programs were
100% effective, focusing only on smoking cessation may
give the public and government leaders the false impression that other prevention strategies are unimportant. In
these counties in particular, cancer prevention strategies
should include policies and programs to reduce other
known cancer risk factors, including environmental and
occupational exposures, at the same time that healthy
lifestyles continue to be promoted.
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